Fig. 4: Leukemia Free and Overall Survival. | Blood Cancer Journal

Fig. 4: Leukemia Free and Overall Survival.

From: Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

Fig. 4

Leukemia-free survival (LFS) at 10 years in the entire study population (A); Leukemia-free survival in patients younger than 51 (B); Leukemia-free survival in patients older than 51 (C); Overall survival (OS) at 10 years in the entire study population (D); Overall survival in patients younger than 51 (E); Overall survival in patients older than 51 (F).

Back to article page